These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6363382)

  • 1. Renal function in patients treated with tobramycin-cefuroxime or tobramycin-penicillin G.
    Trollfors B; Alestig K; Rödjer S; Sandberg T; Westin J
    J Antimicrob Chemother; 1983 Dec; 12(6):641-5. PubMed ID: 6363382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects.
    Rödjer S; Alestig K; Bergmark J; Bergström T; Hultberg B; Jagenburg R; Olaisson L; Trollfors B; Westin J
    J Antimicrob Chemother; 1987 Jul; 20(1):109-16. PubMed ID: 3305460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobramycin and amikacin nephrotoxicity. Value of serum creatinine versus urinary concentration of beta-2-microglobulin.
    Gatell JM; SanMiguel JG; Zamora L; Araujo V; Castells C; Moreno A; Jimenez de Anta MT; Marin JL; Elena M; Ballesta A
    Nephron; 1985; 41(4):337-43. PubMed ID: 3906418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absence of nephrotoxicity and differential nephrotoxicity between tobramycin and gentamicin.
    Kepczyk T; Ryan PJ; McAllister K; Otraje J
    South Med J; 1990 Oct; 83(10):1149-52. PubMed ID: 2218653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.
    Trollfors B; Bergmark J; Hiesche K; Jagenburg R
    Infection; 1984; 12(1):20-2. PubMed ID: 6142864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of cefuroxime and gentamicin in patients with reduced renal function.
    Cockram CS; Richards P; Bax RP
    Curr Med Res Opin; 1980; 6(6):398-403. PubMed ID: 7363640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tolerance of cefpirome (HR 810), a new cephalosporin antibiotic.
    Verho M; Maass L; Malerczyk V; Grötsch H
    Infection; 1987; 15(3):215-9. PubMed ID: 2886437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal toxicity during therapy with gentamicin or tobramycin.
    Keys TF; Kurtz SB; Jones JD; Muller SM
    Mayo Clin Proc; 1981 Sep; 56(9):556-9. PubMed ID: 6115104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function during cefuroxime treatment in patients with pre-existing renal impairment.
    Trollfors B; Suurkula M; Price JD; Norrby R
    J Antimicrob Chemother; 1980 Sep; 6(5):665-70. PubMed ID: 6773920
    [No Abstract]   [Full Text] [Related]  

  • 10. [Potential nephrotoxicity of 2nd generation cephalosporins: cefuroxime versus cefotiam].
    Riegel W; Hörl WH
    Infection; 1993; 21 Suppl 1():S14-6. PubMed ID: 8314287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of adenosine deaminase binding protein in neonates treated with tobramycin.
    Gordjani N; Burghard R; Müller D; Mathäi H; Mergehenn G; Leititis JU; Brandis M
    Pediatr Nephrol; 1995 Aug; 9(4):419-22. PubMed ID: 7577399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.
    Kuhlmann J; Seidel G; Grötsch H
    Infection; 1982; 10(4):233-9. PubMed ID: 6127319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR; Lucarotti RL; Shapiro HS
    Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.
    Felisart J; Rimola A; Arroyo V; Perez-Ayuso RM; Quintero E; Gines P; Rodes J
    Hepatology; 1985; 5(3):457-62. PubMed ID: 3888810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.
    Gatell JM; SanMiguel JG; Araujo V; Zamora L; Maña J; Ferrer M; Bonet M; Bohe M; Jimenez de Anta MT
    Antimicrob Agents Chemother; 1984 Nov; 26(5):766-9. PubMed ID: 6393868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety.
    Kalager T; Andersen BM; Bergan T; Brubakk O; Bruun JN; Døskeland B; Hellum KB; Hopen G; von der Lippe E; Rahm V
    Scand J Infect Dis; 1992; 24(5):637-46. PubMed ID: 1465583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of tobramycin. Value of examining various protein and enzyme markers.
    Ylitalo P; Mörsky P; Parviainen MT; Koivula T
    Methods Find Exp Clin Pharmacol; 1991 May; 13(4):281-7. PubMed ID: 1875778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a single dose of tobramycin on systemic inflammatory response-induced acute kidney injury in a 6-hour porcine model.
    Lipcsey M; Carlsson M; Larsson A; Algotsson L; Eriksson M; Lukinius A; Sjölin J
    Crit Care Med; 2009 Oct; 37(10):2782-90. PubMed ID: 19707126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of renal function in diabetic nephropathy. Comparison of five methods.
    Nordén G; Björck S; Granerus G; Nyberg G
    Nephron; 1987; 47(1):36-42. PubMed ID: 3114657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside and cephalosporin toxicity.
    Noone P
    J Antimicrob Chemother; 1978 Sep; 4(5):465-6. PubMed ID: 690048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.